Login / Signup

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review.

Amira SalimElise HennessyClaire SonnebornOlivia HogueSudipa BiswasMaryAnn MaysAarushi SunejaZubair AhmedIgnacio Fernandez Mata
Published in: CNS drugs (2024)
Dual therapy of anti-CGRP mAbs and onabot may be more efficacious than monotherapy, possibly due to their synergistic mechanisms of action.
Keyphrases
  • combination therapy
  • cross sectional
  • open label
  • stem cells
  • clinical trial